What is experimental medicine?
Experimental medicine is a broad term and refers to:
Advances in non-invasive techniques such as medical imaging, combined with powerful ‘omics technologies, now allow us to approach the human as the ultimate experimental animal for improving human health. Doing so has the potential to dramatically increase the speed and efficiency by which medical discoveries are translated into healthcare.
MRC and experimental medicine
Experimental medicine is a core element of our overarching translational research strategy; studies of disease mechanism in humans play a critical role in realising the potential of a number of research disciplines/approaches of strategic importance to MRC and to UK biomedical science.
The below diagram represents the network of reciprocal interactions between experimental medicine and other research approaches:
Funding opportunities at the MRC
There are opportunities provided by our research boards for investigator-led applications for support across the spectrum of biomedical research. The main funding schemes that are assessed through the board route include research grants, programme grants, New Investigator Research Grants.
For specific note however, there are the following schemes:
Experimental Medicine Challenge Grants
The Experimental Medicine Challenge Grants (EMCG) initiative supports ambitious programmes of research into disease pathophysiology, conducted in humans.
Outline application deadline: 31 May 2018
If you have any questions concerning experimental medicine at MRC, you can contact the MRC Programme Manager for Experimental Medicine:
Dr Rebecca Barlow
firstname.lastname@example.org or email@example.com